Mycophenolate mofetil Completed Phase 2 Trials for Myeloid Leukemias / Myelodysplastic Syndromes (MDS) / Anemias / Neural Tube Defects (NTDs) / Myeloproliferative Disorders / Bone Marrow Transplant Failure Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01392989Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders